Jefferies London Healthcare Conference 2023. Panelists seated left to right: LTS Lohmann CEO Bas van Buijtenen, Axplora CEO Sylke Hassel, and Bachem Holding CEO Thomas Meier (Credit: Reynald Castañeda for Endpoints News)
November 17, 2023 11:08 AM EST
Manufacturing

CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

Anna Brown

News Reporter

If there were two key ideas that sprung from the CD­MO pan­el at this week’s Jef­feries Lon­don Health­care Con­fer­ence, it is that man­u­fac­tur­ers are re­view­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times